AMITY BATES: Open Payments
NPI 1154780591 · RIVERVIEW, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$431 in 22 payments from 10 companies in 2025. Trend: 2023 $288 · 2024 $404 · 2025 $431
Food & beverage: $431
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $112 |
| Novo Nordisk Inc | 5 | $96 |
| PFIZER INC. | 4 | $79 |
| Aimmune Therapeutics, Inc. | 2 | $35 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $18 |
| Boston Scientific Corporation | 1 | $17 |
| Exact Sciences Corporation | 1 | $16 |
| Viatris Specialty LLC | 1 | $15 |
Products named: Wegovy, QULIPTA, PREVNAR 20, ELIQUIS, ZENPEP, UBRELVY, LINZESS, Auvelity.
Industry payments across MI — which companies pay providers there.
